NCT06727071View on ClinicalTrials.gov

Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
Type 1 Diabetes Mellitus
Interventions
PROCEDURE

Hyperglycemic clamp

A continuous infusion of 20% dextrose will be maintained throughout the procedure, while a variable rate of insulin infusion will be used to control participants blood glucose level.

Trial Locations (1)

92037

University of California, San Diego - ACTRI, La Jolla

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of California, San Diego

OTHER